costpurchase

149 results found.

Top Stocks matching your search for "cost purchase"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 4, 2023

It’s not just the efficacy and safety of the produ... See more

Dec, 30, 2022

The analyst comments "TGTX stock is up >15... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
LCID

Lucid Group Inc

-29.21%

$11.57 - $8.19

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 20, 2023

$NIO $XPEV $LI $LCID lifted ,parts to make the ve... See more

Mar, 12, 2023

Also, the cost of eating out is coming down.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 22, 2022

The power of a very low cost basis.

Dec, 2, 2022

$SAVA I’m so excited because my cost is average fo... See more

TGTX

TG Therapeutics Inc

-19.05%

$18.43 - $14.92

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 4, 2023

It’s not just the efficacy and safety of the product, it is the less cost for hospital/infusion, due to one hour infusion and the huge difference in price.

Dec, 30, 2022

The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,

Dec, 30, 2022

Each treatment cost under $10k per treatment.

Dec, 30, 2022

Each treatment cost under $10k per treatment.

Dec, 29, 2022

The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,

LCID

Lucid Group Inc

-29.21%

$11.57 - $8.19

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 20, 2023

$NIO $XPEV $LI $LCID lifted ,parts to make the vehicles to reach demand, and battery 🔋 cost 💲 down !

Mar, 12, 2023

Also, the cost of eating out is coming down.

Feb, 22, 2023

gearing for growth, while simultaneously taking a comprehensive look at reducing costs, and I’m very excited about the opportunities that lie ahead

Feb, 21, 2023

$LCID good news on ER would be 675m in revenue, costs didnt move and guidance to produce around 90k cars.

Jan, 30, 2023

$LCID bought more got my cost under 20

Dec, 9, 2022

lower cost, longer range, lower weight! JACKPOT!

Dec, 8, 2022

manufactoring cost and its better for customers! WINNER!

Dec, 7, 2022

Cost efficient economy cars.

Nov, 18, 2022

Low Cost Micro-Factories 4.

Nov, 12, 2022

Low Cost Micro-Factories 4.

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 22, 2022

The power of a very low cost basis.

Dec, 2, 2022

$SAVA I’m so excited because my cost is average for my shares is $25.87 that’s why hahahahaha you have to be a Short and I’m semi retired hahahaha

Nov, 22, 2022

$SAVA Mike cost this morning was $31.68 This morning not too bad